TSS
ARCT icon

Two Sigma Securities’s Arcturus Therapeutics ARCT Stock Holding History

Two Sigma Securities’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.7K Buy
+11,864
New +$93.5K 0.01% 1333
2021
Q4 		– Sell
-5,232
Closed -$250K – 1534
2021
Q3 		$250K Buy
+5,232
New +$234K 0.01% 1098
2020
Q3 		– Sell
-5,618
Closed -$263K – 1289
2020
Q2 		$263K Buy
+5,618
New +$194K 0.01% 978

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Two Sigma Securities's ARCT Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Arcturus Therapeutics (ARCT) in Q2 2026: 11,864 shares worth $79.7K. The stake represents 0.01% of the portfolio and ranks #1333 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ARCT as recently as Q3 2021.

Two Sigma Securities first reported a position in ARCT in Q2 2020 and has held it in 3 quarters since. The position peaked at $263K in Q2 2020. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Two Sigma Securities held 11,864 shares of Arcturus Therapeutics worth $79.7K as of Q2 2026.
  • Arcturus Therapeutics was a new Two Sigma Securities position in Q2 2026.
  • Arcturus Therapeutics made up 0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1333 holding.
  • Two Sigma Securities first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 3 quarters since.
  • Two Sigma Securities's Arcturus Therapeutics position peaked at $263K in Q2 2020.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.